Bio-Pharma Business Medical Stock Market Technology May 2, 2021 Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease
Business Technology May 2, 2021 Infinite Electronics Adds new Vietnam Distribution Partner for its L-com and Pasternack Brands